| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Zoghbi Huda Y is a Director at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,117 | $900.00 | $1,005,300.00 | -47.3% | +7.1% | -21.0% | |
| Oct 13, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $850.00 | $850,000.00 | -44.5% | +9.1% | +21.0% | |
| Mar 16, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 2,000 | $675.00 | $1,350,000.00 | -64.9% | -19.1% | +10.6% | |
| Sep 14, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $650.00 | $650,002.20 | -35.9% | +2.3% | +8.1% | |
| Jul 7, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,706 | $650.00 | $1,108,900.00 | -72.6% | - | - | |
| Jun 11, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 3,412 | $617.62 | $2,107,318.30 | -20.5% | - | - | |
| May 7, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 5,118 | $566.52 | $2,899,461.05 | -37.5% | - | - |